UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060580
Receipt number R000069292
Scientific Title Research on the effects of fermentable dietary fiber intake and behavioral intervention on bowel movements
Date of disclosure of the study information 2026/02/04
Last modified on 2026/02/04 14:54:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the effects of fermentable dietary fiber intake and behavioral intervention on bowel movements

Acronym

Research on the effects of fermentable dietary fiber intake and behavioral intervention on bowel movements

Scientific Title

Research on the effects of fermentable dietary fiber intake and behavioral intervention on bowel movements

Scientific Title:Acronym

Research on the effects of fermentable dietary fiber intake and behavioral intervention on bowel movements

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects on bowel movements of adult aged 20 to under 50 years old who take in foods containing fermented dietary fiber and undergo behavioral intervention (intestinal massage) for 4 consecutive weeks.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of bowel movements

Key secondary outcomes

Bowel Movement Status (Number of bowel movements, Stool volume, Bristol Stool Scale, Stool odor, Sense of relief after bowel movement)
Urinary indoxyl sulfate
Urinary 8-OHdG
JPAC-QOL
Physical Examination (Body Measurement)
Skin-Related Questionnaire


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Intake of foods containing fermented dietary fiber and behavioral intervention (intestinal massage) for 4 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2. Japanese who are 20 years old or more and under 50 years old
3. Persons who had 3 or more bowel movements per week but fewer than 21 bowel movements per week during screening

Key exclusion criteria

1. Persons who have chronic illness, receiving medication, have a serious disease history
2. Persons who are allergic to the test food (especially wheat, eggs, milk, soybeans, peaches, almonds, and oranges)
3. Persons who usually take a large amount of test food
4. Persons who regularly do intestinal massages
5. Persons who usually take a large amount of dietary fiber
6. Persons who usually take medicine, health functional foods, or other foods expected to have prebiotic or probiotic effects that may influence bowel movements or the intestinal environment.
7. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam
8. Persons who were judged as inappropriate for study participants by the principal investigator
9. Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Takamasa
Middle name
Last name Masuda

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place Bld. 5F, 5-27-1, Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Email

masudat@hc-sys.jp


Public contact

Name of contact person

1st name Takamasa
Middle name
Last name Masuda

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place Bld. 5F, 5-27-1, Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Homepage URL


Email

masudat@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Mizkan Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 02 Month 04 Day

Date of IRB


Anticipated trial start date

2026 Year 02 Month 09 Day

Last follow-up date

2026 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 02 Month 04 Day

Last modified on

2026 Year 02 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069292